• FDA Approves Trikafta, 1st Vertex Triple Combo with Potential to Treat 90% of CF Patients
  • 1st Patient Enrolled in Phase 2 Study of Inhalation Treatment for All with CF, Boehringer Says
  • First Patients Dosed in Trial Testing MS1819-SD Plus PERT for CF-related Severe EPI, AzurRX Says
  • Regular Exercise Promotes Lung Health in CF by Lowering Adiponectin Levels, Study Suggests
  • Chelsea Financial Services Supporting Boomer Esiason Foundation, CF Research at NYC Marathon
  • The Art of Not Helping
  • Orkambi of Definite Benefit But Risk Evident in Patients Who Can’t Tolerate It, French Study Finds
  • I’m Grateful for the Journey That Led to My Service Dog
  • Preventing the Spread of Misinformation
  • UNITY Prenatal Blood Test Accurate at Diagnosing CF, Other Hereditary Diseases, Study Shows
  • Viral Respiratory Tract Infections in Young CF Children Usually Mild, Study Found
  • FDA Designates Vast’s BIOC11 a Qualified Infectious Disease Product
Average Rating
0 out of 5 stars. 0 votes.
My Rating: